Purple Biotech Analyst Ratings
Purple Biotech Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/30/2023 | 662.71% | HC Wainwright & Co. | $7 → $9 | Maintains | Buy |
| 07/21/2023 | 577.97% | JonesTrading | → $8 | Initiates Coverage On | → Buy |
| 05/17/2023 | 493.22% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
| 05/17/2023 | 832.2% | Chardan Capital | → $11 | Reiterates | Buy → Buy |
| 02/09/2023 | 493.22% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 02/09/2023 | 832.2% | Chardan Capital | → $11 | Reiterates | → Buy |
| 10/17/2022 | 493.22% | HC Wainwright & Co. | → $7 | Initiates Coverage On | → Buy |
| 09/08/2022 | 832.2% | Chardan Capital | → $11 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年08月30日 | 662.71% | HC Wainwright公司 | $7→$9 | 維護 | 買 |
| 07/21/2023 | 577.97% | Jones Trading | →$8 | 開始承保 | →購買 |
| 2023年05月17日 | 493.22% | HC Wainwright公司 | →$7 | 重申 | 購買→購買 |
| 2023年05月17日 | 832.2% | 查爾丹資本 | →$11 | 重申 | 購買→購買 |
| 02/09/2023 | 493.22% | HC Wainwright公司 | →$7 | 重申 | →購買 |
| 02/09/2023 | 832.2% | 查爾丹資本 | →$11 | 重申 | →購買 |
| 10/17/2022 | 493.22% | HC Wainwright公司 | →$7 | 開始承保 | →購買 |
| 09/08/2022 | 832.2% | 查爾丹資本 | →$11 | 開始承保 | →購買 |
What is the target price for Purple Biotech (PPBT)?
紫色生物科技公司(PPBT)的目標價是多少？
The latest price target for Purple Biotech (NASDAQ: PPBT) was reported by HC Wainwright & Co. on August 30, 2023. The analyst firm set a price target for $9.00 expecting PPBT to rise to within 12 months (a possible 662.71% upside). 8 analyst firms have reported ratings in the last year.
紫生物技術公司(納斯達克代碼：PPBT)的最新目標價是由HC Wainwright&Co.於2023年8月30日報道的。這家分析公司將目標價定為9美元，預計購買力平價將在12個月內上漲(可能上漲662.71%)。去年有8家分析公司公佈了評級。
What is the most recent analyst rating for Purple Biotech (PPBT)?
紫色生物科技公司(PPBT)的最新分析師評級是多少？
The latest analyst rating for Purple Biotech (NASDAQ: PPBT) was provided by HC Wainwright & Co., and Purple Biotech maintained their buy rating.
分析師對紫色生物科技公司(納斯達克代碼：PPBT)的最新評級由HC Wainwright&Co.提供，紫色生物科技公司維持買入評級。
When is the next analyst rating going to be posted or updated for Purple Biotech (PPBT)?
紫色生物科技(PPBT)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Purple Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Purple Biotech was filed on August 30, 2023 so you should expect the next rating to be made available sometime around August 30, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Purple Biotech的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。紫色生物技術的上一次評級是在2023年8月30日提交的，所以你應該預計下一次評級將在2024年8月30日左右的某個時候公佈。
Is the Analyst Rating Purple Biotech (PPBT) correct?
分析師對紫色生物科技(PPBT)的評級正確嗎？
While ratings are subjective and will change, the latest Purple Biotech (PPBT) rating was a maintained with a price target of $7.00 to $9.00. The current price Purple Biotech (PPBT) is trading at is $1.18, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的紫色生物技術(PPBT)評級維持不變，目標價在7.00美元至9.00美元之間。紫色生物科技(PPBT)目前的交易價格為1.18美元，超出了分析師的預測區間。
譯文內容由第三人軟體翻譯。